APO Research

APO RESEARCH · REPORT

C-C Chemokine Receptor Type 5

Selected research

Market Structure

Global C-C Chemokine Receptor Type 5 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global C-C Chemokine Receptor Type 5 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for C-C Chemokine Receptor Type 5 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for C-C Chemokine Receptor Type 5 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for C-C Chemokine Receptor Type 5 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for C-C Chemokine Receptor Type 5 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of C-C Chemokine Receptor Type 5 include Allergan Plc, American Gene Technologies International Inc, Bristol-Myers Squibb Company, ChemoCentryx Inc, Cytodyn Inc, Pharis Biotec GmbH, GlaxoSmithKline Plc and TaiwanJ Pharmaceuticals Co Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global C-C Chemokine Receptor Type 5 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of C-C Chemokine Receptor Type 5 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents C-C Chemokine Receptor Type 5 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the C-C Chemokine Receptor Type 5 market size, projected growth trends, production technologies, key applications, and end-use industries.

C-C Chemokine Receptor Type 5 Segment by Company

Allergan Plc

American Gene Technologies International Inc

Bristol-Myers Squibb Company

ChemoCentryx Inc

Cytodyn Inc

Pharis Biotec GmbH

GlaxoSmithKline Plc

TaiwanJ Pharmaceuticals Co Ltd

C-C Chemokine Receptor Type 5 Segment by Type

DS-001

CCL-14

BMS-813160

AG-1105

Others

C-C Chemokine Receptor Type 5 Segment by Application

Infectious Disease

Immunology

Gastrointestinal

Oncology

Others

C-C Chemokine Receptor Type 5 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C-C Chemokine Receptor Type 5 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of C-C Chemokine Receptor Type 5 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C-C Chemokine Receptor Type 5.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the C-C Chemokine Receptor Type 5 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of C-C Chemokine Receptor Type 5 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of C-C Chemokine Receptor Type 5 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of C-C Chemokine Receptor Type 5 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. C-C Chemokine Receptor Type 5 Industry Trends Table 2. C-C Chemokine Receptor Type 5 Industry Drivers Table 3. C-C Chemokine Receptor Type 5 Industry Opportunities and Challenges Table 4. C-C Chemokine Receptor Type 5 Industry Restraints Table 5. Global C-C Chemokine Receptor Type 5 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global C-C Chemokine Receptor Type 5 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global C-C Chemokine Receptor Type 5 Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global C-C Chemokine Receptor Type 5 Sales Market Share by Manufacturers Table 9. Global C-C Chemokine Receptor Type 5 Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global C-C Chemokine Receptor Type 5 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global C-C Chemokine Receptor Type 5 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global C-C Chemokine Receptor Type 5 Manufacturers, Product Type & Application Table 13. Global C-C Chemokine Receptor Type 5 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global C-C Chemokine Receptor Type 5 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of DS-001 Table 17. Major Manufacturers of CCL-14 Table 18. Major Manufacturers of BMS-813160 Table 19. Major Manufacturers of AG-1105 Table 20. Major Manufacturers of Others Table 21. Global C-C Chemokine Receptor Type 5 Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 22. Global C-C Chemokine Receptor Type 5 Sales by Type (2021-2026) & (W Units) Table 23. Global C-C Chemokine Receptor Type 5 Sales by Type (2027-2032) & (W Units) Table 24. Global C-C Chemokine Receptor Type 5 Sales Market Share by Type (2021-2026) Table 25. Global C-C Chemokine Receptor Type 5 Sales Market Share by Type (2027-2032) Table 26. Global C-C Chemokine Receptor Type 5 Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 27. Global C-C Chemokine Receptor Type 5 Revenue by Type (2021-2026) & (W Units) Table 28. Global C-C Chemokine Receptor Type 5 Revenue by Type (2027-2032) & (W Units) Table 29. Global C-C Chemokine Receptor Type 5 Revenue Market Share by Type (2021-2026) Table 30. Global C-C Chemokine Receptor Type 5 Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Infectious Disease Table 32. Major Manufacturers of Immunology Table 33. Major Manufacturers of Gastrointestinal Table 34. Major Manufacturers of Oncology Table 35. Major Manufacturers of Others Table 36. Global C-C Chemokine Receptor Type 5 Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 37. Global C-C Chemokine Receptor Type 5 Sales by Application (2021-2026) & (W Units) Table 38. Global C-C Chemokine Receptor Type 5 Sales by Application (2027-2032) & (W Units) Table 39. Global C-C Chemokine Receptor Type 5 Sales Market Share by Application (2021-2026) Table 40. Global C-C Chemokine Receptor Type 5 Sales Market Share by Application (2027-2032) Table 41. Global C-C Chemokine Receptor Type 5 Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 42. Global C-C Chemokine Receptor Type 5 Revenue by Application (2021-2026) & (W Units) Table 43. Global C-C Chemokine Receptor Type 5 Revenue by Application (2027-2032) & (W Units) Table 44. Global C-C Chemokine Receptor Type 5 Revenue Market Share by Application (2021-2026) Table 45. Global C-C Chemokine Receptor Type 5 Revenue Market Share by Application (2027-2032) Table 46. Global C-C Chemokine Receptor Type 5 Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 47. Global C-C Chemokine Receptor Type 5 Sales by Region (2021-2026) & (W Units) Table 48. Global C-C Chemokine Receptor Type 5 Sales Market Share by Region (2021-2026) Table 49. Global C-C Chemokine Receptor Type 5 Sales Forecasted by Region (2027-2032) & (W Units) Table 50. Global C-C Chemokine Receptor Type 5 Sales Forecasted Market Share by Region (2027-2032) Table 51. North America C-C Chemokine Receptor Type 5 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 52. North America C-C Chemokine Receptor Type 5 Sales by Country (2021-2026) & (W Units) Table 53. North America C-C Chemokine Receptor Type 5 Sales by Country (2027-2032) & (W Units) Table 54. Europe C-C Chemokine Receptor Type 5 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Europe C-C Chemokine Receptor Type 5 Sales by Country (2021-2026) & (W Units) Table 56. Europe C-C Chemokine Receptor Type 5 Sales by Country (2027-2032) & (W Units) Table 57. Asia Pacific C-C Chemokine Receptor Type 5 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 58. Asia Pacific C-C Chemokine Receptor Type 5 Sales by Country (2021-2026) & (W Units) Table 59. Asia Pacific C-C Chemokine Receptor Type 5 Sales by Country (2027-2032) & (W Units) Table 60. South America, Middle East and Africa C-C Chemokine Receptor Type 5 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 61. South America, Middle East and Africa C-C Chemokine Receptor Type 5 Sales by Country (2021-2026) & (W Units) Table 62. South America, Middle East and Africa C-C Chemokine Receptor Type 5 Sales by Country (2027-2032) & (W Units) Table 63. Global C-C Chemokine Receptor Type 5 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global C-C Chemokine Receptor Type 5 Revenue by Region (2021-2026) & (US$ Million) Table 65. Global C-C Chemokine Receptor Type 5 Revenue by Region (2027-2032) & (US$ Million) Table 66. Global C-C Chemokine Receptor Type 5 Revenue Market Share by Region (2021-2026) Table 67. Global C-C Chemokine Receptor Type 5 Revenue Market Share by Region (2027-2032) Table 68. Allergan Plc Company Information Table 69. Allergan Plc Business Overview Table 70. Allergan Plc C-C Chemokine Receptor Type 5 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Allergan Plc C-C Chemokine Receptor Type 5 Product Portfolio Table 72. Allergan Plc Recent Development Table 73. American Gene Technologies International Inc Company Information Table 74. American Gene Technologies International Inc Business Overview Table 75. American Gene Technologies International Inc C-C Chemokine Receptor Type 5 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. American Gene Technologies International Inc C-C Chemokine Receptor Type 5 Product Portfolio Table 77. American Gene Technologies International Inc Recent Development Table 78. Bristol-Myers Squibb Company Company Information Table 79. Bristol-Myers Squibb Company Business Overview Table 80. Bristol-Myers Squibb Company C-C Chemokine Receptor Type 5 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Bristol-Myers Squibb Company C-C Chemokine Receptor Type 5 Product Portfolio Table 82. Bristol-Myers Squibb Company Recent Development Table 83. ChemoCentryx Inc Company Information Table 84. ChemoCentryx Inc Business Overview Table 85. ChemoCentryx Inc C-C Chemokine Receptor Type 5 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. ChemoCentryx Inc C-C Chemokine Receptor Type 5 Product Portfolio Table 87. ChemoCentryx Inc Recent Development Table 88. Cytodyn Inc Company Information Table 89. Cytodyn Inc Business Overview Table 90. Cytodyn Inc C-C Chemokine Receptor Type 5 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Cytodyn Inc C-C Chemokine Receptor Type 5 Product Portfolio Table 92. Cytodyn Inc Recent Development Table 93. Pharis Biotec GmbH Company Information Table 94. Pharis Biotec GmbH Business Overview Table 95. Pharis Biotec GmbH C-C Chemokine Receptor Type 5 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Pharis Biotec GmbH C-C Chemokine Receptor Type 5 Product Portfolio Table 97. Pharis Biotec GmbH Recent Development Table 98. GlaxoSmithKline Plc Company Information Table 99. GlaxoSmithKline Plc Business Overview Table 100. GlaxoSmithKline Plc C-C Chemokine Receptor Type 5 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. GlaxoSmithKline Plc C-C Chemokine Receptor Type 5 Product Portfolio Table 102. GlaxoSmithKline Plc Recent Development Table 103. TaiwanJ Pharmaceuticals Co Ltd Company Information Table 104. TaiwanJ Pharmaceuticals Co Ltd Business Overview Table 105. TaiwanJ Pharmaceuticals Co Ltd C-C Chemokine Receptor Type 5 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. TaiwanJ Pharmaceuticals Co Ltd C-C Chemokine Receptor Type 5 Product Portfolio Table 107. TaiwanJ Pharmaceuticals Co Ltd Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. C-C Chemokine Receptor Type 5 Distributors List Table 111. C-C Chemokine Receptor Type 5 Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. C-C Chemokine Receptor Type 5 Product Image Figure 2. Global C-C Chemokine Receptor Type 5 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global C-C Chemokine Receptor Type 5 Market Size (2021-2032) & (US$ Million) Figure 4. Global C-C Chemokine Receptor Type 5 Sales (2021-2032) & (W Units) Figure 5. Global C-C Chemokine Receptor Type 5 Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 C-C Chemokine Receptor Type 5 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. DS-001 Image Figure 9. CCL-14 Image Figure 10. BMS-813160 Image Figure 11. AG-1105 Image Figure 12. Others Image Figure 13. Global C-C Chemokine Receptor Type 5 Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global C-C Chemokine Receptor Type 5 Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global C-C Chemokine Receptor Type 5 Sales Market Share by Type (2021-2032) Figure 16. Global C-C Chemokine Receptor Type 5 Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 17. Global C-C Chemokine Receptor Type 5 Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global C-C Chemokine Receptor Type 5 Revenue Market Share by Type (2021-2032) Figure 19. Infectious Disease Image Figure 20. Immunology Image Figure 21. Gastrointestinal Image Figure 22. Oncology Image Figure 23. Others Image Figure 24. Global C-C Chemokine Receptor Type 5 Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 25. Global C-C Chemokine Receptor Type 5 Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global C-C Chemokine Receptor Type 5 Sales Market Share by Application (2021-2032) Figure 27. Global C-C Chemokine Receptor Type 5 Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 28. Global C-C Chemokine Receptor Type 5 Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global C-C Chemokine Receptor Type 5 Revenue Market Share by Application (2021-2032) Figure 30. North America C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 31. North America C-C Chemokine Receptor Type 5 Sales Market Share by Country (2021-2032) Figure 32. U.S. C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Canada C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Mexico C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Europe C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Europe C-C Chemokine Receptor Type 5 Sales Market Share by Country (2021-2032) Figure 37. Germany C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 38. France C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 39. U.K. C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Italy C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Netherlands C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Asia Pacific C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Asia Pacific C-C Chemokine Receptor Type 5 Sales Market Share by Country (2021-2032) Figure 44. China C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Japan C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South Korea C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 47. Southeast Asia C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 48. India C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Australia C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 50. South America, Middle East and Africa C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 51. South America, Middle East and Africa C-C Chemokine Receptor Type 5 Sales Market Share by Country (2021-2032) Figure 52. Brazil C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 53. South Africa C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Saudi Arabia C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Turkey C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Argentina C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 57. UAE C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 58. Egypt C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 59. Chile C-C Chemokine Receptor Type 5 Sales and Growth Rate (2021-2032) & (W Units) Figure 60. Global C-C Chemokine Receptor Type 5 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global C-C Chemokine Receptor Type 5 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America C-C Chemokine Receptor Type 5 Revenue (2021-2032) & (US$ Million) Figure 63. North America C-C Chemokine Receptor Type 5 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe C-C Chemokine Receptor Type 5 Revenue (2021-2032) & (US$ Million) Figure 65. Europe C-C Chemokine Receptor Type 5 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific C-C Chemokine Receptor Type 5 Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific C-C Chemokine Receptor Type 5 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa C-C Chemokine Receptor Type 5 Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa C-C Chemokine Receptor Type 5 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. C-C Chemokine Receptor Type 5 Value Chain Figure 71. Manufacturing Cost Structure Figure 72. C-C Chemokine Receptor Type 5 Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • DS-001
  • CCL-14
  • BMS-813160
  • AG-1105
  • Others
Applications
  • Infectious Disease
  • Immunology
  • Gastrointestinal
  • Oncology
  • Others
Companies covered
  • Allergan Plc
  • American Gene Technologies International Inc
  • Bristol-Myers Squibb Company
  • ChemoCentryx Inc
  • Cytodyn Inc
  • Pharis Biotec GmbH
  • GlaxoSmithKline Plc
  • TaiwanJ Pharmaceuticals Co Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global C-C Chemokine Receptor Type 5 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global C-C Chemokine Receptor Type 5 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global C-C Chemokine Receptor Type 5 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global C-C Chemokine Receptor Type 5 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global C-C Chemokine Receptor Type 5 Market Dynamics
  1. 2.1 C-C Chemokine Receptor Type 5 Industry Trends
  2. 2.2 C-C Chemokine Receptor Type 5 Industry Drivers
  3. 2.3 C-C Chemokine Receptor Type 5 Industry Opportunities and Challenges
  4. 2.4 C-C Chemokine Receptor Type 5 Industry Restraints
3 C-C Chemokine Receptor Type 5 Market by Manufacturers
  1. 3.1 Global C-C Chemokine Receptor Type 5 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global C-C Chemokine Receptor Type 5 Sales by Manufacturers (2021-2026)
  3. 3.3 Global C-C Chemokine Receptor Type 5 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global C-C Chemokine Receptor Type 5 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global C-C Chemokine Receptor Type 5 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global C-C Chemokine Receptor Type 5 Manufacturers, Product Type & Application
  7. 3.7 Global C-C Chemokine Receptor Type 5 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global C-C Chemokine Receptor Type 5 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 C-C Chemokine Receptor Type 5 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 C-C Chemokine Receptor Type 5 Tier 1, Tier 2, and Tier 3
4 C-C Chemokine Receptor Type 5 Market by Type
  1. 4.1 C-C Chemokine Receptor Type 5 Type Introduction
  2. 4.1.1 DS-001
  3. 4.1.2 CCL-14
  4. 4.1.3 BMS-813160
  5. 4.1.4 AG-1105
  6. 4.1.5 Others
  7. 4.2 Global C-C Chemokine Receptor Type 5 Sales by Type
  8. 4.2.1 Global C-C Chemokine Receptor Type 5 Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global C-C Chemokine Receptor Type 5 Sales by Type (2021-2032)
  10. 4.2.3 Global C-C Chemokine Receptor Type 5 Sales Market Share by Type (2021-2032)
  11. 4.3 Global C-C Chemokine Receptor Type 5 Revenue by Type
  12. 4.3.1 Global C-C Chemokine Receptor Type 5 Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global C-C Chemokine Receptor Type 5 Revenue by Type (2021-2032)
  14. 4.3.3 Global C-C Chemokine Receptor Type 5 Revenue Market Share by Type (2021-2032)
5 C-C Chemokine Receptor Type 5 Market by Application
  1. 5.1 C-C Chemokine Receptor Type 5 Application Introduction
  2. 5.1.1 Infectious Disease
  3. 5.1.2 Immunology
  4. 5.1.3 Gastrointestinal
  5. 5.1.4 Oncology
  6. 5.1.5 Others
  7. 5.2 Global C-C Chemokine Receptor Type 5 Sales by Application
  8. 5.2.1 Global C-C Chemokine Receptor Type 5 Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global C-C Chemokine Receptor Type 5 Sales by Application (2021-2032)
  10. 5.2.3 Global C-C Chemokine Receptor Type 5 Sales Market Share by Application (2021-2032)
  11. 5.3 Global C-C Chemokine Receptor Type 5 Revenue by Application
  12. 5.3.1 Global C-C Chemokine Receptor Type 5 Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global C-C Chemokine Receptor Type 5 Revenue by Application (2021-2032)
  14. 5.3.3 Global C-C Chemokine Receptor Type 5 Revenue Market Share by Application (2021-2032)
6 Global C-C Chemokine Receptor Type 5 Sales by Region
  1. 6.1 Global C-C Chemokine Receptor Type 5 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global C-C Chemokine Receptor Type 5 Sales by Region (2021-2032)
  3. 6.2.1 Global C-C Chemokine Receptor Type 5 Sales by Region (2021-2026)
  4. 6.2.2 Global C-C Chemokine Receptor Type 5 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America C-C Chemokine Receptor Type 5 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America C-C Chemokine Receptor Type 5 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe C-C Chemokine Receptor Type 5 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe C-C Chemokine Receptor Type 5 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific C-C Chemokine Receptor Type 5 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific C-C Chemokine Receptor Type 5 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa C-C Chemokine Receptor Type 5 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa C-C Chemokine Receptor Type 5 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global C-C Chemokine Receptor Type 5 Revenue by Region
  1. 7.1 Global C-C Chemokine Receptor Type 5 Revenue by Region
  2. 7.1.1 Global C-C Chemokine Receptor Type 5 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global C-C Chemokine Receptor Type 5 Revenue by Region (2021-2026)
  4. 7.1.3 Global C-C Chemokine Receptor Type 5 Revenue by Region (2027-2032)
  5. 7.1.4 Global C-C Chemokine Receptor Type 5 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America C-C Chemokine Receptor Type 5 Revenue (2021-2032)
  8. 7.2.2 North America C-C Chemokine Receptor Type 5 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe C-C Chemokine Receptor Type 5 Revenue (2021-2032)
  11. 7.3.2 Europe C-C Chemokine Receptor Type 5 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific C-C Chemokine Receptor Type 5 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific C-C Chemokine Receptor Type 5 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa C-C Chemokine Receptor Type 5 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa C-C Chemokine Receptor Type 5 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Allergan Plc
  2. 8.1.1 Allergan Plc Company Information
  3. 8.1.2 Allergan Plc Business Overview
  4. 8.1.3 Allergan Plc C-C Chemokine Receptor Type 5 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Allergan Plc C-C Chemokine Receptor Type 5 Product Portfolio
  6. 8.1.5 Allergan Plc Recent Developments
  7. 8.2 American Gene Technologies International Inc
  8. 8.2.1 American Gene Technologies International Inc Company Information
  9. 8.2.2 American Gene Technologies International Inc Business Overview
  10. 8.2.3 American Gene Technologies International Inc C-C Chemokine Receptor Type 5 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 American Gene Technologies International Inc C-C Chemokine Receptor Type 5 Product Portfolio
  12. 8.2.5 American Gene Technologies International Inc Recent Developments
  13. 8.3 Bristol-Myers Squibb Company
  14. 8.3.1 Bristol-Myers Squibb Company Company Information
  15. 8.3.2 Bristol-Myers Squibb Company Business Overview
  16. 8.3.3 Bristol-Myers Squibb Company C-C Chemokine Receptor Type 5 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bristol-Myers Squibb Company C-C Chemokine Receptor Type 5 Product Portfolio
  18. 8.3.5 Bristol-Myers Squibb Company Recent Developments
  19. 8.4 ChemoCentryx Inc
  20. 8.4.1 ChemoCentryx Inc Company Information
  21. 8.4.2 ChemoCentryx Inc Business Overview
  22. 8.4.3 ChemoCentryx Inc C-C Chemokine Receptor Type 5 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ChemoCentryx Inc C-C Chemokine Receptor Type 5 Product Portfolio
  24. 8.4.5 ChemoCentryx Inc Recent Developments
  25. 8.5 Cytodyn Inc
  26. 8.5.1 Cytodyn Inc Company Information
  27. 8.5.2 Cytodyn Inc Business Overview
  28. 8.5.3 Cytodyn Inc C-C Chemokine Receptor Type 5 Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cytodyn Inc C-C Chemokine Receptor Type 5 Product Portfolio
  30. 8.5.5 Cytodyn Inc Recent Developments
  31. 8.6 Pharis Biotec GmbH
  32. 8.6.1 Pharis Biotec GmbH Company Information
  33. 8.6.2 Pharis Biotec GmbH Business Overview
  34. 8.6.3 Pharis Biotec GmbH C-C Chemokine Receptor Type 5 Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pharis Biotec GmbH C-C Chemokine Receptor Type 5 Product Portfolio
  36. 8.6.5 Pharis Biotec GmbH Recent Developments
  37. 8.7 GlaxoSmithKline Plc
  38. 8.7.1 GlaxoSmithKline Plc Company Information
  39. 8.7.2 GlaxoSmithKline Plc Business Overview
  40. 8.7.3 GlaxoSmithKline Plc C-C Chemokine Receptor Type 5 Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GlaxoSmithKline Plc C-C Chemokine Receptor Type 5 Product Portfolio
  42. 8.7.5 GlaxoSmithKline Plc Recent Developments
  43. 8.8 TaiwanJ Pharmaceuticals Co Ltd
  44. 8.8.1 TaiwanJ Pharmaceuticals Co Ltd Company Information
  45. 8.8.2 TaiwanJ Pharmaceuticals Co Ltd Business Overview
  46. 8.8.3 TaiwanJ Pharmaceuticals Co Ltd C-C Chemokine Receptor Type 5 Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 TaiwanJ Pharmaceuticals Co Ltd C-C Chemokine Receptor Type 5 Product Portfolio
  48. 8.8.5 TaiwanJ Pharmaceuticals Co Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 C-C Chemokine Receptor Type 5 Value Chain Analysis
  2. 9.1.1 C-C Chemokine Receptor Type 5 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 C-C Chemokine Receptor Type 5 Production Mode & Process
  6. 9.2 C-C Chemokine Receptor Type 5 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 C-C Chemokine Receptor Type 5 Distributors
  9. 9.2.3 C-C Chemokine Receptor Type 5 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research